359例肺癌相关性贫血的中医药应用分析  

Analysis of traditional Chinese medicine in 359 cases of lung cancer related anemia

作　　者：曹兆平[1] 代兴斌[1] 田劭丹[2] 孙雪梅[3] 

机构地区：[1]南京中医药大学,南京210023 [2]北京中医药大学东直门医院,北京100700 [3]南京中医药大学附属医院,南京210029

出　　处：《中药药理与临床》2015年第1期256-258,共3页Pharmacology and Clinics of Chinese Materia Medica

基　　金：北京市科委2012年度科技计划重大项目;项目名称:中医药提升恶性肿瘤疗效系统研究(D131100002213002)

摘　　要：目的:调查分析肺癌相关性贫血的中药应用规律。方法:收集近7年在江苏省中医院住院的肺癌相关性贫血且接受中药复方治疗的病例资料,对中药应用情况进行分析。结果:共收集病例资料359份,男性患者居多,多处于肿瘤晚期,主要以轻中度贫血为主。使用频率从高到底的前20味中药依次为甘草、茯苓、白术、谷芽、麦芽、陈皮、薏苡仁、麦冬、半夏、太子参、浙贝母、苦杏仁、南沙参、山药、枳壳、白花蛇舌草、桔梗、北沙参、黄芪、神曲。按药物功效分,补虚药使用率最高(28.04%),其他依次为化痰止咳平喘药(13.95%)、清热药(11.86%)、消食药(10.17%)、利水渗湿药(8.45%)、理气药(6.68%)、活血化瘀药(5.68%)等。补虚药以补气药(50.54%)为主,其次是补阴药(36.13%)、补血药(10.83%)和补阳药(2.5%)。结论:肺癌相关贫血的治疗用药应立足于确切的病因病机辨证,体现中医整体观和辨证观。肺癌的形成是一个缓慢而复杂的过程,从而决定了肺癌相关性贫血的病因病机的复杂性和多样性,从而决定了肺癌相关贫血中医药治疗的多方面、多层次性。Objective： To investigate the application rule of lung cancer related anemia treatment with TCM. Methods： Conduct analysis of TCM application of patients. These patients from Jiangsu provincial hospital of TCM in the recent seven years were diagnosed with lung cancer related anemia and had been treated with traditional Chinese medicine. Results： In the studied 359 cases,men were in majority. Most of them were advanced cancer and mild-to-moderate anemia. The top 20 in usage frequency were licorice root,poria,atractylodes,fructus setariae germinatus,malt,dried tangerine or orange peel,coix seed,dwarf lilyturf,pinellia,radix pseudostellariae,zhejiang fritillary,bitter almond,nansha ginseng,Chinese yam,orange,spreading hedyotis herb,radix platycodi,coastal glehnia root,astragalus root and medicated leave. From the drug efficacy,tonifying medicinal was the most common（ 28. 04%）. The usage frequency of expectorant cough suppressant and anti-asthmatic drug,heat-clearing medicinal,digestant medicinal,damp-draining diuretic,qi-regulating medicinal and blood-activating and stasis-resolving medicinal were 13. 95%,11. 86%,10. 17%,8. 45%,6. 68% and 5. 68%,respectively. Tonifying medicinal were mainly qi-tonifying medicinal（ 50. 54%）,followed by yin-tonifying medicinal（ 36. 13%）,blood-tonifying medicinal（ 10. 83%） and yang-tonifying medicinal（ 2. 5%）. Conclusions： The syndrome differentiation of lung cancer related anemia treatment should be based on exact etiology and pathogensis. Meanwhile,holism and dialectic of TCM were reflected. As the onset and progression of lung cancer is a slow and complicated process,the etiology and pathogensis of lung cancer related anemia are complex and the treatment with TCM are universality and hierarchical.

关 键 词：肺癌 贫血 中医药治疗 

分 类 号：R273[医药卫生—中西医结合]